Thread by @wong_yujun

🌎Global CLEARED registry by @JasmohanBajaj

n=1,383; Reason for admission: GI bleeding🩸, HE🧠
✅Infection🦠: 25%
✅AKI: 46%
✅30-D Readmission: 33%
🪦30-D Mortality: 33%
😟Transplant: 11%

#ILC2022 #LiverTwitter @EASLedu

Recruitment/selection policy on post-LTx in ACLF-3 by Dr Thierry 🇫🇷

🪦3-year survival: ACLF-3 ⬇️ 66% vs 82%
✅Volume ⏫, survival ⏫
✅Survival gap diminished btw #ACLF-3 vs non-AC LF 3👍

How?

💡MDT, post-ICU care, TAM score, surgery/anes
✅ICU network (list from ICU)
#ILC2022

⛔️When not to transplant #ACLF-3?

Combination of:
💡Age, Lactate, MDR infection, Respiratory

Give⏲️

#ILC2022 #Livertwitter

🔥Real-world long-term albumin (LTA) by @wim_laleman

n = 6,660 (2,355 LTA) from 🇮🇹
Duration: 14 months (Q2weekly)
50%⬇️ Paracentesis
20% ⬇️Refractory ascites
50% ⬇️SBP
40% ⬇️HRS
⬇️hospitalization/patient

🤔Selection bias - LTA vs non-LTA by physicians

#ILC2022 #LiverTwitter

#Cirrhosis 🫀 by Dr. Simona Bota

✅Prospective study, n=133, 70%🍻#cirrhosis
🤔Does heart, etiology & severity of cirrhosis -> AKI
Diagnosis🫀: GLS
✅AKI 19.5%; 🫀 15%

Predictor of AKI: 🍻 & 🫀

#ILC2022 #LiverTwitter #alcohol

🤩Drink☕️no⚰️